Literature DB >> 17574969

Association of the BRCA1 missense variant R1699W with a malignant phyllodes tumor of the breast.

Kerstin Rhiem1, Uta Flucke, Christoph Engel, Barbara Wappenschmidt, Axel Reinecke-Lüthge, Reinhard Büttner, Rita Katharina Schmutzler.   

Abstract

Familial breast carcinomas that are attributable to BRCA1 or BRCA2 mutations have characteristic morphologic and immunhistochemical features. BRCA1-associated carcinomas are poorly differentiated infiltrating ductal carcinomas frequently exhibiting morphologic features of typical or atypical medullary carcinomas such as prominent lymphocytic infiltrate and pushing margins. We report on a patient carrying the deleterious BRCA1 germline mutation R1699W, who presented with a malignant phyllodes tumor of the breast. The re-investigation of archival material by a reference pathologist of the German Consortium for Hereditary Breast and Ovarian Cancer (GCHBOC) revealed BRCA-associated pronounced pushing margins. In a total of 618 unrelated index patients who are registered in the GCHBOC database, no other phyllodes tumor has been described, while 10 carriers of the R1699W mutant have been identified. We conclude that the histopathologic appearance of the phyllodes tumor indicates an association with the BRCA1 mutation R1699W although it is a rare event in BRCA-positive families.

Entities:  

Mesh:

Year:  2007        PMID: 17574969     DOI: 10.1016/j.cancergencyto.2007.03.006

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

Review 1.  Malignant Phyllodes Tumor of the Breast: A Practice Review.

Authors:  Ângelo Bezerra de Souza Fede; Ronaldo Pereira Souza; Mauricio Doi; Marina De Brot; Cynthia Aparecida Bueno de Toledo Osorio; Guilherme Rocha Melo Gondim; Jose Claudio Casali-da-Rocha; Rima Jbili; Almir Galvao Vieira Bitencourt; Juliana Alves de Souza; Rafael Caparica Bitton; Fabiana Baroni Alves Makdissi; Solange Moraes Sanches
Journal:  Clin Pract       Date:  2021-04-06

Review 2.  Phyllodes Tumors: A Scoping Review of the Literature.

Authors:  Jessica Bogach; Saad Shakeel; Frances C Wright; Nicole J Look Hong
Journal:  Ann Surg Oncol       Date:  2021-07-22       Impact factor: 5.344

3.  First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report.

Authors:  Carla B Ripamonti; Mara Colombo; Patrizia Mondini; Manoukian Siranoush; Bernard Peissel; Loris Bernard; Paolo Radice; Maria Luisa Carcangiu
Journal:  BMC Cancer       Date:  2013-02-01       Impact factor: 4.430

4.  BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.

Authors:  Artur Kowalik; Monika Siołek; Janusz Kopczyński; Kamila Krawiec; Joanna Kalisz; Sebastian Zięba; Beata Kozak-Klonowska; Elżbieta Wypiórkiewicz; Jowita Furmańczyk; Ewelina Nowak-Ozimek; Małgorzata Chłopek; Paweł Macek; Jolanta Smok-Kalwat; Stanisław Góźdź
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.